CGuard EPS
Commercial- Indications
- Carotid artery disease
Company intelligence / Profile preview
Ovalum Ltd. was a privately held medical device company founded in 2005 with the goal to develop and commercialize safe and effective technologies for vascular interventions. The company's main achievement reported was the announcement in February 2008 that its proprietary technology had been used successfully for the first time in US clinical procedures. There have been no further public updates about products, leadership, funding rounds, acquisitions, or ongoing operations since that time—suggesting that Ovalum Ltd. may now be inactive or defunct as there are also no active website or business directory listings found after this period.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ovalum.